Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy

BACKGROUND: The prognosis of lung cancer patients with interstitial lung disease (ILD) is poor, and acute exacerbation (AE) of ILD can occur during chemotherapy as a fatal adverse event. Although AE‐ILD development is correlated with various factors, no reports are investigating the disease activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekine, Akimasa, Matama, Goushi, Hagiwara, Eri, Tabata, Erina, Ikeda, Satoshi, Oda, Tsuneyuki, Okuda, Ryo, Kitamura, Hideya, Baba, Tomohisa, Satoh, Hiroaki, Misumi, Toshihiro, Komatsu, Shigeru, Iwasawa, Tae, Ogura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436679/
https://www.ncbi.nlm.nih.gov/pubmed/35840339
http://dx.doi.org/10.1111/1759-7714.14566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436679/
https://www.ncbi.nlm.nih.gov/pubmed/35840339
http://dx.doi.org/10.1111/1759-7714.14566

Ejemplares similares